US Says 2 Die After Taking Biogen Idec, Inc. (Massachusetts) And Genentech, Inc. Drug Rituxan; Shares Fall

WASHINGTON, Dec 18 (Reuters) - Two lupus patients died from a rare brain infection after taking the Genentech Inc. and Biogen Idec Inc. drug Rituxan, U.S. health officials said in an advisory issued on Monday.

>>> Discuss This Story